Stock SGBCF SHANGHAI HENLIUS BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Shanghai Henlius Biotech, Inc. OTC Markets

Equities

SGBCF

CNE100003N76

Market Closed - OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Shanghai Henlius Biotech, Inc. -.--% -.--%
May. 14 Shanghai Henlius Biotech Gets Go-Ahead for Clinical Trials of Breast Cancer Drug in China MT
May. 14 Shanghai Henlius Biotech, Inc. Announces Approval of Application for Clinical Trials of HLX78 (lasofoxifene) by the National Medical Products Administration CI
a7121f5026f7e52c1897a4f.9qR4QylTDMAYNqPAAJdJCgoQrzWllU1s5aaWwAFF7j4.nfwAdl8FaaReWuCsLc46RFpdzEfQ4WAfhM_nkDIOmg2ZzkkMbAdDs2AO6g~de017a13b66f9170050cafcfd961efba
  1. Stock Market
  2. Equities
  3. 2696 Stock
  4. SGBCF Stock
  5. Charts Shanghai Henlius Biotech, Inc.
  6. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW